Predictors of survival in patients undergoing oropharyngeal surgery for cancer recurrence after radiation therapy
- 19 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Archives of Oto-Rhino-Laryngology
- Vol. 277 (7), 2085-2093
- https://doi.org/10.1007/s00405-020-05913-z
Abstract
Purpose The incidence of oropharyngeal squamous cell carcinoma continues to rise with the majority of patients receiving definitive or adjunctive radiation. For patients with locoregional recurrence after radiation, optimal treatment involves salvage surgery. The aim of this study is to identify factors that predict survival to ultimately improve patient selection for salvage surgery. Methods Retrospective cohort study at an NCI-designated cancer center. We analyzed patients with a history of head and neck radiation who presented with persistent/recurrent or second primary disease requiring salvage oropharyngeal resection from 1998–2017 (n = 120). Patients were stratified into three classes based on time to recurrence and presence of laryngopharyngeal dysfunction. Primary outcomes were 5-year overall survival (OS) and disease specific survival (DSS). Results Median OS was 27 months (median follow-up 20 months). Five-year OS was 47% for class I (recurrence > 2 years), 26% for class II (recurrence ≤ 2 years), and 0% for class III (recurrence ≤ 2 years and laryngopharyngeal dysfunction), (p < 0.0001). Five-year DSS showed significant differences between classes (p < 0.0001). On multivariate analysis, class remained predictive of OS (p = 0.04– < 0.001) and DSS (p = 0.04–0.001). Adjuvant radiation after salvage surgery with negative margins showed superior OS (71% vs. 28%, p = 0.01) and DSS (83% vs 37%, p = 0.02) compared to surgery alone and was a significant predictor of improved survival on multivariate analysis (HR 0.1, p = 0.04). Conclusion This study identified a subset of patients with oropharyngeal cancer recurrence within two years of initial treatment and with laryngopharyngeal dysfunction who have poor outcomes for salvage surgery.Keywords
Funding Information
- National Institutes of Health (T32 DC005356)
- American Cancer Society (132034-RSG-18-062-01-TBG)
- National Cancer Institute (K08CA226350-02)
This publication has 37 references indexed in Scilit:
- Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancerThe Laryngoscope, 2012
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesJournal of Clinical Oncology, 2011
- Surgical salvage of the oropharynx after failure of organ‐sparing therapyHead & Neck, 2011
- Second salvage surgery for re‐recurrent oral cavity and oropharynx carcinomaHead & Neck, 2010
- The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynxCancer, 2009
- Prognostic Factors for Survival After Salvage Reirradiation of Head and Neck CancerJournal of Clinical Oncology, 2009
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI Journal of the National Cancer Institute, 2008
- Time to recurrence of squamous cell carcinoma of the head and neckHead & Neck, 1991
- Surgical management of postradiation residual/recurrent cancer of the base of the tongueJournal of Surgical Oncology, 1980
- Recurrence patterns in squamous cell carcinoma of the oral cavity, pharynx, and larynxJournal of Surgical Oncology, 1974